The efficacy of biologics for the treatment of Crohn's disease (CD) is affected by the drug concentrations. We aimed to evaluate the importance of albumin and globulin which are known to be associated with drug concentrations as prognostic biomarkers in CD.

中文翻译：

---

抗肿瘤坏死因子 α 治疗后 1 年的白蛋白与球蛋白比率可作为小儿克罗恩病患者的预后生物标志物。

生物制剂治疗克罗恩病 (CD) 的疗效受药物浓度的影响。我们旨在评估已知与药物浓度相关的白蛋白和球蛋白作为 CD 预后生物标志物的重要性。